Cancer is one of the leading causes of human death worldwide. Treatment of cancer
exhausts significant medical resources, and the morbidity and mortality caused by cancer is …

Artificial intelligence (AI) has been a very active research topic over the last years and
thoracic imaging has particularly benefited from the development of AI and in particular deep …

Background We comprehensively analyzed the global burdens and trends in incidence and
mortality of tracheal, bronchus, and lung (TBL) cancer among subgroups of distinctive ages …

Tumor derived exosomes (TEXs) have emerged as promising biomarkers for cancer liquid
biopsy. Conventional methods (such as ELISA and qRT-PCR) and emerging biosensing …

Background The NLST reported a significant 20% reduction in lung cancer mortality with
three annual low-dose CT (LDCT) screens and the Dutch-Belgian NELSON trial indicates a …

Background The impact of the first coronavirus disease 2019 (COVID-19) wave on cancer
patient management was measured within the nationwide network of the Unicancer …

Lung cancer is the leading cause of cancer-related deaths worldwide. Molecular profiling
has contributed to a new classification of lung cancer, driving advancements in research and …

Kirsten rat sarcoma (KRAS) is the most commonly mutated oncogene in lung cancers. Gene
therapy is emerging as a promising cancer treatment modality; however, the systemic …

Automatic pulmonary nodule detection is the most crucial technology in early diagnosis of
lung cancer and early treatment. However, the various nodule type, shape and size …

Lung cancer causes more deaths than breast, cervical, and colorectal cancer combined.
Nevertheless, population‐based lung cancer screening is still not considered standard …